Abstract
Polypurine/polypyrimidine (pPu/pPy) tracts, which exist in the promoter regions of many growth-related genes, have been proposed to be very dynamic in their conformation. In this chapter, we describe a detailed protocol for DNase I and S1 nuclease footprinting experiments with supercoiled plasmid DNA containing the promoter regions to probe whether there are conformational transitions to B-type DNA, melted DNA, and G-quadruplex structures within this tract. This is demonstrated with the proximal promoter region of the human vascular endothelial growth factor (VEGF) gene, which also contains multiple binding sites for Sp1 and Egr-1 transcription factors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
McCarthy JG, Heywood SM (1987) A long polypyrimidine/polypurine tract induces an altered DNA conformation on the 3′ coding region of the adjacent myosin heavy chain gene. Nucleic Acids Res 15:8069-8085
Michelotti GA, Michelotti EF, Pullner A, Duncan RC, Eick D, Levens D (1996) Multiple single-stranded cis elements are associated with activated chromatin of the human c-myc gene in vivo. Mol Cell Biol 16:2656-2669
Shi Q, Le X, Abbruzzese JL, Peng Z, Qian CN, Tang H et al (2001) Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res 61:4143-4154
Rustighi A, Tessari MA, Vascotto F, Sgarra R, Giancotti V, Manfioletti G (2002) A polypyrimidine/polypurine tract within the Hmga2 minimal promoter: a common feature of many growth-related genes. Biochemistry 41:1229-1240
Cogoi S, Xodo LE (2006) G-quadruplex formation within the promoter of the KRAS protooncogene and its effect on transcription. Nucleic Acids Res 34:2536-2549
De Armond R, Wood S, Sun D, Hurley LH, Ebbinghaus SW (2005) Evidence for the presence of a guanine quadruplex forming region within a polypurine tract of the hypoxia inducible factor 1α promoter. Biochemistry 44:16341-16350
Guo K, Pourpak A, Beetz-Rogers K, Gokhale V, Sun D, Hurley LH (2007) Formation of pseudosymmetrical G-quadruplex and i-motif structures in the proximal promoter region of the RET oncogene. J Am Chem Soc 129:10220-10228
Pullner A, Mautner J, Albert T, Eick D (1996) Nucleosomal structure of active and inactive c-myc genes. J Biol Chem 271:31452-31457
Wang Z, Lin XH, Qiu QQ, Deuel TF (1992) Modulation of transcription of the platelet-derived growth factor A-chain gene by a promoter region sensitive to S1 nuclease. J Biol Chem 267:17022-17031
Siebenlist U, Henninghausen L, Battey J, Leder P (1984) Chromatin structure and protein binding in the putative regulatory region of the c-myc gene in Burkitt lymphoma. Cell 37:381-391
Evans T, Efstratiadis A (1986) Sequence-dependent S1 nuclease hypersensitivity of a heteronomous DNA duplex. J Biol Chem 261:14771-14780
Benham CJ (1985) Theoretical analysis of conformational equilibria in superhelical DNA. Ann Rev Biophys Biophysical Chem 14:23-45
Liu LF, Wang JC (1987) Supercoiling of the DNA template during transcription. Proc Natl Acad Sci USA 84:7024-7027
Williams DL, Kowalski D (1993) Easily unwound DNA sequences and hairpin structures in the Epstein-Barr virus origin of plasmid replication. J Virol 67:2707-2715
Kouzine F, Levens D (2007) Supercoil-driven DNA structures regulate genetic transactions. Front Biosci 12:4409-4423
Kouzine F, Sanford S, Elisha-Feil Z, Levens D (2008) The functional response of upstream DNA to dynamic supercoiling in vivo. Nat Struct Mol Biol 15:146-154
Folkman J (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29:15-18
Sullivan DC, Bicknell R (2003) New molecular pathways in angiogenesis. Br J Cancer 89:228-231
Martiny-Baron G, Marme D (1995) VEGF-mediated tumour angiogenesis: a new target for cancer therapy. Curr Opin Biotechnol 6:675-680
Goodsell DS (2003) The molecular perspective: VEGF and angiogenesis. Stem Cells 21:118-119
Jain RK (2002) Tumor angiogenesis and accessibility: role of vascular endothelial growth factor. Semin Oncol 29:3-9
Gunningham SP, Currie MJ, Han C, Turner K, Scott PA, Robinson BA et al (2001) Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia. Cancer Res 61:3206-3211
Schafer G, Cramer T, Suske G, Kemmner W, Wiedenmann B, Hocker M (2003) Oxidative stress regulates vascular endothelial growth factor-A gene transcription through Sp1- and Sp3-dependent activation of two proximal GC-rich promoter elements. J Biol Chem 278:8190-8198
Maeno T, Tanaka T, Sando Y, Suga T, Maeno Y, Nakagawa J et al (2002) Stimulation of vascular endothelial growth factor gene transcription by all trans retinoic acid through Sp1 and Sp3 sites in human bronchioloalveolar carcinoma cells. Am J Respir Cell Mol Biol 26:246-253
Chen H, Ye D, Xie X, Chen B, Lu W (2004) VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma. Gynecol Oncol 94:630-635
Pal S, Datta K, Khosravi-Far R, Mukhopadhyay D (2001) Role of protein kinase Czeta in Ras-mediated transcriptional activation of vascular permeability factor/vascular endothelial growth factor expression. J Biol Chem 276:2395-2403
Tanaka T, Kanai H, Sekiguchi K, Aihara Y, Yokoyama T, Arai M et al (2000) Induction of VEGF gene transcription by IL-1 beta is mediated through stress-activated MAP kinases and Sp1 sites in cardiac myocytes. J Mol Cell Cardiol 32:1955-1967
Finkenzeller G, Sparacio A, Technau A, Marme D, Siemeister G (1997) Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression. Oncogene 15:669-676
Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD et al (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604-4613
Sun D, Guo K, Rusche JJ, Hurley LH (2005) Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents. Nucleic Acids Res 33:6070-6080
Saluz HP, Jost JP (1993) Approaches to characterize protein-DNA interactions in vivo. Crit Rev Eukaryot Gene Expr 3:1-29
Dabrowiak JC, Goodisman J, Ward B (1997) Quantitative DNA footprinting. Methods Mol Biol 90:23-42
Kim MY, Vankayalapati H, Shin-Ya K, Wierzba K, Hurley LH (2002) Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular G-quadruplex. J Am Chem Soc 124:2098-2099
Acknowledgments
This research was supported by grants from the National Institutes of Health (CA109069). We are grateful to Drs. Allison Hays and Keith Fox for proofreading and editing the final version of the manuscript and figures. We also thank Drs Keping Xie and Kazuo Shin-ya for providing pGL3-V789 and telomestatin, respectively, for this study.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Sun, D. (2010). In vitro Footprinting of Promoter Regions Within Supercoiled Plasmid DNA. In: Fox, K. (eds) Drug-DNA Interaction Protocols. Methods in Molecular Biology, vol 613. Humana Press. https://doi.org/10.1007/978-1-60327-418-0_14
Download citation
DOI: https://doi.org/10.1007/978-1-60327-418-0_14
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-417-3
Online ISBN: 978-1-60327-418-0
eBook Packages: Springer Protocols